Fulminant autoimmune cortical encephalitis associated with thymoma treated with plasma exchange

Mayo Clinic Proceedings

Volumn 75, Issue 12, 2000, Pages 1321-1326

  Rickman, Otis B ^a   Parisi, Joseph E ^a   Yu, Zhiya ^a   Lennon, Vanda A ^b   Vernino, Steven ^b  

^a Department of Internal Medicine ^*  (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARBAMAZEPINE; CHOLINERGIC RECEPTOR ANTIBODY; CLONAZEPAM; LORAZEPAM; METHYLPREDNISOLONE; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; SEMAPHORIN; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; ENCEPHALITIS; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; STEROID THERAPY; THYMOMA;

EID: 0033667777     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.12.1321     Document Type: Article

References (25)

1. Corsellis JA. Goldberg GJ, Norton AR. "Limhic encephalitis" and its association with carcinoma. Brain. 1968:91:481-496.
2. Brierly JB, Corsellis JAN. Hierons R, Nevin S. Subacute encephalitis of later adult life mainly affecting the limbic areas. Brain. 1960:83:357-368.
3. Lucchinetti CF. Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type l antineuronal nuclear autoantibodies. Neurology. 1998:50:652-657.
4. Cunningham JD. Burt ME. Limbic encephalitis secondary to malignant thymoma. Ann Thorac Surg. 1994:58:250-251.
5. Antoine JC, Honnorut J. Anterion CT, et al. Limbic encephalitis and immunological perturbations in two patients with thymoma. J Neurol Ni-urosurg Psychiatry. 1995:58:706-710.
6. Ingenito GG, Berger JR, David NJ. Norenberg MD. Limbic encephalitis associated with thymoma. Neurology. 1990:40:382.
7. McArdle JP. Millingen KS. Limbic encephalitis associated with malignant thymoma. Pathology. 1988:20:292-295.
8. Voltz R, Gultekin SH, Rosenfeld MR, et al. A sérologie marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Eng/ J Med. 1999:340:1788-1795.
9. Rosenow EC III, Hurley BT. Disorders of the thymus: a review. Arch Intern Med. 1984; 144:763-770.
10. Wilcox N. Myasthenia gravis. Curr Opin Immunol. 1993:5:910917.
11. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome): report of five cases and literature review. Brain. 1993;! 16(pt 2):453-469.
12. Souadjian JV, Enriquez P, Silverstein MN, Pépin JM. The spectrum of diseases associated with thymoma: coincidence or syndrome? Arch Intern Med. 1974;134:374-379.
13. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF. Thymoma: a clinicopathologic review. Cancer. 1987;60: 2727-2743.
14. Dau PC, Lindstrom JM, Cassel CK, Denys EH, Shev EE, Spitler LE. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Eng! J Med. 1977;297:1134-1140.
15. Mahalati K, Dawson RB, Collins JO, Mayer RF. Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management. J Clin Apheresis. 1999; 14:1-8.
16. Lennon VA. Serologie profile of myasthenia gravis and distinction from the Lambert-Eaton myasthénie syndrome. Neurology. 1997; 48(suppl 5):S23-S27.
17. Howard FM Jr, Lennon VA, Finley J, Matsumoto J, Elveback LR. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N YAcad Sd. 1987:505:526-538.
18. Yu Z, Kryzer TJ, Griesmann GE, Kirn K-K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma related autoimmunity. Ann Neurol, In press.
19. Vernino S, Adamski J, Kryzer TJ, Fealey RD, Lennon VA. Neuronal nicotinic ACh receptor antibody in subacute autonomie neuropathy and cancer-related syndromes. Neurology. 1998;50: 1806-1813.
20. Vernino S, Lennon VA. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol. 2000;47:297-305.
21. Graus F, Vega F, Delattre JY, et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology. 1992;42(3, pt 1):536540.
22. Kodama T, Numaguchi Y, Gellad FE, Dwyer BA, Kristt DA. Magnetic resonance imaging of limbic encephalitis. Neuroradiology. 1991;33:520-523.
23. Glantz MJ, Biran H, Myers ME, Gockerman JP, Friedberg MH. The radiographie diagnosis and treatment of paraneoplastic central nervous system disease. Cancer. 1994;73:168-175.
24. Bakheit AM, Kennedy PG, Behan PO. Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psychiatry. 1990:53:1084-1088.
25. Cuenoud S, Feltkamp TE, Fulpius BW, Oosterhuis HJ. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis. Neurology. 1980;30:201-202.